Vitamin D-mediated tsRNA-07804 triggers mitochondrial dysfunction and suppresses non-small cell lung cancer

Yonggang Liang1, Xiaoqiang Zhang1, Jinhua Peng1

  • 1Department of Thoracic Surgery, The Second Affiliated Hospital of Nanchang University, Nanchang, 330006, China.

Abstract

Insights

Vitamin D combats non-small cell lung cancer (NSCLC) by regulating tRNA-derived small RNA (tsRNA)-07804, which targets CRKL, thereby improving mitochondrial function and inhibiting tumor growth.

Area of Science:

  • Molecular Biology
  • Oncology
  • Biochemistry

Background:

  • tRNA-derived small RNAs (tsRNAs) are emerging non-coding RNAs with diverse roles in cancer.
  • The precise mechanisms by which vitamin D influences mitochondrial dysfunction and non-small cell lung cancer (NSCLC) progression via tsRNAs are not fully understood.

Purpose of the Study:

  • To investigate the role of vitamin D in regulating tsRNAs and their impact on mitochondrial dysfunction and NSCLC progression.
  • To elucidate the specific tsRNA involved and its downstream molecular targets in NSCLC.

Main Methods:

  • Small RNA sequencing was used to identify differentially expressed tsRNAs in vitamin D-treated NSCLC cells.
  • In vitro cell assays and in vivo animal models were employed to assess the functional effects of vitamin D and tsRNA-07804 on NSCLC.
  • Mechanism was explored using dual-luciferase reporter assays, qPCR, and western blotting to examine the tsRNA-07804/CRKL interaction.

Main Results:

  • Vitamin D treatment led to mitochondrial dysfunction in NSCLC cells and upregulated tsRNA-07804.
  • tsRNA-07804 mediated vitamin D's effects, inhibiting NSCLC proliferation, migration, and invasion while promoting apoptosis by suppressing CRKL expression.
  • In vivo studies confirmed that vitamin D inhibited tumor growth by increasing tsRNA-07804 expression, and clinical samples showed a negative correlation between tsRNA-07804 and CRKL.

Conclusions:

  • Vitamin D suppresses NSCLC progression and mitochondrial dysfunction via the tsRNA-07804/CRKL axis.
  • tsRNA-07804 emerges as a potential therapeutic target for NSCLC treatment.

Related Concept Videos

Electron Transport Chain: Complex I and II01:46

Electron Transport Chain: Complex I and II

The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
13.4K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.6K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.8K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.6K
Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
4.8K